This inventor holds 2 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ibaraki, JP (2001)
- Tsukuba, JP (2002)
Company Filing History:
Years Active: 2001-2002
Title: Tetsuya Kimizuka: Innovator in Pharmaceutical Chemistry
Introduction
Tetsuya Kimizuka is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target central nervous system disorders. With a total of 2 patents to his name, Kimizuka's work is recognized for its potential therapeutic applications.
Latest Patents
Among his latest patents is a groundbreaking invention related to amide derivatives or salts thereof. This patent includes a tricyclic pyrrole or pyrazole derivative, represented by a specific general formula. This compound exhibits strong affinity and selectivity for the 5-HT receptor, making it useful for treating various central nervous system diseases, including sexual disorders, eating disorders, anxiety, depression, and sleeping disorders.
Career Highlights
Kimizuka is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding of drug interactions within the central nervous system.
Collaborations
Throughout his career, Kimizuka has collaborated with notable colleagues, including Tatsuya Maruyama and Takayuki Suzuki. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.
Conclusion
Tetsuya Kimizuka's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His patents reflect a commitment to addressing critical health issues through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile